Cancer papers

Head & neck cancers research papers

Papers tagged to Head & neck cancers. Adjust filters if you want a narrower scope.

5 papersSorted by most recent

Topics

Treatment, Diagnosis

Modality

Radiation, Imaging

Study type

Not listed

Abstract

Prophylactic percutaneous endoscopic gastrostomy (PEG) placement for nutritional management prior to chemoradiotherapy is a common procedure in patients with head and neck cancer, for which serious complications are rare. Herein, we present a case of abdominal wall abscess that developed 12 days following prophylactic…

Authors

Ryuji Okamoto, Hironori Sunakawa, Yuji Owaki, Hiroaki Oka +3

AI-generated summary

Abdominal Wall Abscess after Prophylactic Percutaneous Endoscopic Gastrostomy Placement in a Patient Undergoing Chemoradiotherapy for Laryngeal Cancer. reports: Prophylactic percutaneous endoscopic gastrostomy (PEG) placement for nutritional management prior to chemoradiotherapy is a common procedure in patients with head and neck cancer, for which serious complications are rare. Herein, we present a case of abdominal wall abscess that developed 12 days following prophylactic PEG placement in a patient with laryngeal cancer. This rare complication was initially difficult to diagnose due to subtle abdominal symptoms.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Topics

Prevention / Risk

Modality

Surgery, Imaging

Study type

Not listed

Abstract

Abstract not available.

Authors

Rachel Wijayarathna, Gareth D Jones, Samantha Ringshall, Eui-Sik Suh +3

AI-generated summary

Summary not available yet.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Novel Compounds as TIPARP Inhibitors for Treating Head and Neck Squamous Cell Carcinoma (HNSCC).
ACS medicinal chemistry letters • 2026-02-12 • DOI: 10.1021/acsmedchemlett.6c00001
Peer-reviewedImpact 61

Topics

Not listed

Modality

Targeted therapy

Study type

Not listed

Abstract

Provided herein are novel compounds as TIPARP inhibitors, pharmaceutical compositions, use of such compounds in treating head and neck squamous cell carcinoma (HNSCC), and processes for preparing such compounds.

Authors

Ram W Sabnis

AI-generated summary

Novel Compounds as TIPARP Inhibitors for Treating Head and Neck Squamous Cell Carcinoma (HNSCC). reports: Provided herein are novel compounds as TIPARP inhibitors, pharmaceutical compositions, use of such compounds in treating head and neck squamous cell carcinoma (HNSCC), and processes for preparing such compounds.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Peer-reviewedImpact 65

Topics

Treatment

Modality

Surgery, Imaging

Study type

Not listed

Abstract

Laryngectomy is a life-changing procedure typically performed as a surgical treatment for patients with head and neck cancer. Voice conversion (VC) is a technology that converts one voice into another without changing the linguistic information. Recently, "Save the Voice Project" for patients planning to…

Authors

Naoki Nishio, Kazuhiro Kobayashi, Ding Ma, Sohei Mitani +2

AI-generated summary

A Voice Conversion System from Electrolarynx Speech to Preoperative Patient's Speech for Total Laryngectomy. reports: Laryngectomy is a life-changing procedure typically performed as a surgical treatment for patients with head and neck cancer. Voice conversion (VC) is a technology that converts one voice into another without changing the linguistic information. Recently, "Save the Voice Project" for patients planning to undergo laryngectomy using our VC technique has been initiated.

This summary may be inaccurate. Verify with the primary paper.

Primary source: PubMed.

Topics

Treatment, Screening / Early detection, Biology / Mechanism, Outcomes / Survival, Prevention / Risk

Modality

Imaging

Study type

Not listed

Abstract

Head and neck cancer (HNC) is the sixth most common cancer globally. Incidence and survival rates vary significantly across geographic regions and tumor subsites. This is partly due to differences in risk factor exposure, which includes tobacco smoking, alcohol consumption and human papillomavirus (HPV)…

Authors

Gormley, M., Adhikari, A., Dudding, T., Pring, M. +28

AI-generated summary

VOYAGER: an international consortium investigating the role of human papilloma virus and genetics in oral and oropharyngeal cancer risk and survival reports: Head and neck cancer (HNC) is the sixth most common cancer globally. Incidence and survival rates vary significantly across geographic regions and tumor subsites. This is partly due to differences in risk factor exposure, which includes tobacco smoking, alcohol consumption and human papillomavirus (HPV) infection, alongside detection and treatment strategies. This is a preprint and not peer reviewed.

This summary may be inaccurate. Verify with the primary paper.

Primary source: medRxiv (not peer reviewed).